
Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy
Keywords: فیبروز میوکارد; Astragaloside IV; Myocardial fibrosis; Dilated cardiomyopathy; TGF-β1; Coxsackievirus B3; Viral myocarditis